ARTEMISMED
₹278.38-4.49 (-1.59%)
Quarterly ResultsProfit & LossBalance SheetCash Flow
Key Insights
POSITIVE
- Net sales increased to ₹239.9 crore, indicating strong demand in the latest quarter.
- Operating profit margin improved to 6.8%, showing better cost management and efficiency.
- Net profit rose to ₹22.92 crore, reflecting positive financial health and profitability growth.
NEGATIVE
- Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
- Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
- Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
| Field | Trend | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 218.78 | 225.24 | 223.20 | 241.42 | 232.39 | 239.90 | 254.96 | 274.70 | |
| Expenses | 204.26 | 206.90 | 205.97 | 218.31 | 214.38 | 223.58 | 232.10 | 242.98 | |
| Operating Profit | 14.53 | 18.34 | 17.24 | 23.11 | 18.01 | 16.32 | 22.86 | 31.72 | |
| Other Income | 1.78 | 1.90 | 4.40 | 7.44 | 8.80 | 12.35 | 6.93 | 7.65 | |
| Interest | 7.96 | 8.57 | 8.13 | 7.98 | 8 | 7.83 | 7.38 | 7.19 | |
| Depreciation | 10.16 | 11.04 | 10.80 | 11.17 | 11.45 | 11.74 | 11.16 | 11.71 | |
| Profit Before Tax | 16.31 | 20.24 | 21.64 | 30.55 | 26.81 | 28.66 | 29.79 | 39.38 | |
| Tax | 4.76 | 5.93 | 5.12 | 8.42 | 6.21 | 5.74 | 8.59 | 9.37 | |
| Net Profit | 11.55 | 14.30 | 16.52 | 22.13 | 20.60 | 22.92 | 21.20 | 30 | |
| EPS in Rs | 0.85 | 1.04 | 1.14 | 1.42 | 1.32 | 1.47 | 1.35 | 1.90 |